Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift von Alimohamed, Nimira, Sridhar, Srikala S.

Volltext

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up von Powles, Thomas, Park, Se Hoon, Caserta, Claudia, Valderrama, Begoña P, Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S, Sternberg, Cora N, Bellmunt, Joaquim, Aragon-Ching, Jeanny B, Wang, Jing, Huang, Bo, Laliberte, Robert J, di Pietro, Alessandra, Grivas, Petros

Volltext

Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer? von Sridhar, Srikala S.

Volltext

Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial von Powles, Thomas, Sridhar, Srikala S., Loriot, Yohann, Bellmunt, Joaquim, Mu, Xinmeng Jasmine, Ching, Keith A., Pu, Jie, Sternberg, Cora N., Petrylak, Daniel P., Tambaro, Rosa, Dourthe, Louis M., Alvarez-Fernandez, Carlos, Aarts, Maureen, di Pietro, Alessandra, Grivas, Petros, Davis, Craig B.

Volltext

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic von Kulkarni, Girish S, Hermanns, Thomas, Wei, Yanliang, Bhindi, Bimal, Satkunasivam, Raj, Athanasopoulos, Paul, Bostrom, Peter J, Kuk, Cynthia, Li, Kathy, Templeton, Arnoud J, Sridhar, Srikala S, van der Kwast, Theodorus H, Chung, Peter, Bristow, Robert G, Milosevic, Michael, Warde, Padraig, Fleshner, Neil E, Jewett, Michael A S, Bashir, Shaheena, Zlotta, Alexandre R

Volltext

Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors von Jubber, Ibrahim, Ong, Sean, Bukavina, Laura, Black, Peter C., Compérat, Eva, Kamat, Ashish M., Kiemeney, Lambertus, Lawrentschuk, Nathan, Lerner, Seth P., Meeks, Joshua J., Moch, Holger, Necchi, Andrea, Panebianco, Valeria, Sridhar, Srikala S., Znaor, Ariana, Catto, James W.F., Cumberbatch, Marcus G.

Volltext

The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer von Stecca, Carlos, Mitin, Timur, Sridhar, Srikala S.

Volltext

Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE Study von Stecca, Carlos, Abdeljalil, Osama, Sridhar, Srikala S.

Volltext

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma von Powles, Thomas, Park, Se Hoon, Voog, Eric, Caserta, Claudia, Valderrama, Begoña P, Gurney, Howard, Kalofonos, Haralabos, Radulović, Siniša, Demey, Wim, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S, Tsuchiya, Norihiko, Kopyltsov, Evgeny, Sternberg, Cora N, Bellmunt, Joaquim, Aragon-Ching, Jeanny B, Petrylak, Daniel P, Laliberte, Robert, Wang, Jing, Huang, Bo, Davis, Craig, Fowst, Camilla, Costa, Nuno, Blake-Haskins, John A, di Pietro, Alessandra, Grivas, Petros

Volltext

Impact of age at diagnosis of de novo metastatic prostate cancer on survival von Bernard, Brandon, Burnett, Colin, Sweeney, Christopher J., Rider, Jennifer R., Sridhar, Srikala S.

Volltext

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer von Fizazi, Karim, Piulats, Josep M., Reaume, M. Neil, Ostler, Peter, McDermott, Ray, Gingerich, Joel R., Pintus, Elias, Sridhar, Srikala S., Bambury, Richard M., Emmenegger, Urban, Lindberg, Henriette, Morris, David, Nolè, Franco, Staffurth, John, Redfern, Charles, Sáez, María I., Abida, Wassim, Daugaard, Gedske, Heidenreich, Axel, Krieger, Laurence, Sautois, Brieuc, Loehr, Andrea, Despain, Darrin, Heyes, Catherine A., Watkins, Simon P., Chowdhury, Simon, Ryan, Charles J., Bryce, Alan H.

Volltext

EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma von Rosenberg, Jonathan, Sridhar, Srikala S, Zhang, Jingsong, Smith, David, Ruether, Dean, Flaig, Thomas W, Baranda, Joaquina, Lang, Joshua, Plimack, Elizabeth R, Sangha, Randeep, Heath, Elisabeth I, Merchan, Jamie, Quinn, David I, Srinivas, Sandy, Milowsky, Matthew, Wu, Chunzhang, Gartner, Elaina M, Zuo, Peiying, Melhem-Bertrandt, Amal, Petrylak, Daniel P

Volltext

Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet? von Sridhar, Srikala S., North, Scott A., Blais, Normand

Volltext

Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice von Grivas, Petros, Agarwal, Neeraj, Pal, Sumanta, Kalebasty, Arash Rezazadeh, Sridhar, Srikala S., Smith, Jodi, Devgan, Geeta, Sternberg, Cora N., Bellmunt, Joaquim

Volltext

Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking von Poudineh, Mahla, Aldridge, Peter M., Ahmed, Sharif, Green, Brenda J., Kermanshah, Leyla, Nguyen, Vivian, Tu, Carmen, Mohamadi, Reza M., Nam, Robert K., Hansen, Aaron, Sridhar, Srikala S., Finelli, Antonio, Fleshner, Neil E., Joshua, Anthony M., Sargent, Edward H., Kelley, Shana O.

Volltext

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer von Jiang, Di Maria, Gupta, Shilpa, Kitchlu, Abhijat, Meraz-Munoz, Alejandro, North, Scott A., Alimohamed, Nimira S., Blais, Normand, Sridhar, Srikala S.

Volltext

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer von Powles, Thomas, Carroll, Danielle, Chowdhury, Simon, Gravis, Gwenaelle, Joly, Florence, Carles, Joan, Fléchon, Aude, Maroto, Pablo, Petrylak, Daniel, Rolland, Frédéric, Cook, Natalie, Balar, Arjun V., Sridhar, Srikala S., Galsky, Matthew D., Grivas, Petros, Ravaud, Alain, Jones, Robert, Cosaert, Jan, Hodgson, Darren, Kozarewa, Iwanka, Mather, Richard, McEwen, Robert, Mercier, Florence, Landers, Dónal

Volltext

Notch signaling pathway as a therapeutic target in breast cancer von Al-Hussaini, Hamed, Subramanyam, Deepa, Reedijk, Michael, Sridhar, Srikala S

Volltext

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis von Zlotta, Alexandre R, Ballas, Leslie K, Niemierko, Andrzej, Lajkosz, Katherine, Kuk, Cynthia, Miranda, Gus, Drumm, Michael, Mari, Andrea, Thio, Ethan, Fleshner, Neil E, Kulkarni, Girish S, Jewett, Michael A S, Bristow, Robert G, Catton, Charles, Berlin, Alejandro, Sridhar, Srikala S, Schuckman, Anne, Feldman, Adam S, Wszolek, Matthew, Dahl, Douglas M, Lee, Richard J, Saylor, Philip J, Michaelson, M Dror, Miyamoto, David T, Zietman, Anthony, Shipley, William, Chung, Peter, Daneshmand, Siamak, Efstathiou, Jason A

Volltext

Metastatic Urothelial Cancer: a rapidly changing treatment landscape von Stecca, Carlos, Abdeljalil, Osama, Sridhar, Srikala S.

Volltext